← Leaderboards
Ellen Van Der Plas
Arkansas Children'S Hospital Res Inst
$2,055,804
Attributed
$2,055,804
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $559.5K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,055,804 · 1
By mechanism
R37$2,055,804 · 1
Top collaborators
No co-investigators on record.
Most similar at Arkansas Children'S Hospital Res Inst
Same institution · by research overlap
- Lisa Tjorven Jansen$345,319
Others in their field
Other Rising Stars on “Early Childhood”
- Christine W Hockett · Avera Mckennan$8,908,366
- Matthew Morrow Engelhard · Duke University$7,519,665
- Sunni L. Mumford · University Of Pennsylvania$6,439,627
- Burton Rochelson · Feinstein Institute For Medical Research$5,891,324
- Katherine Rivera-Spoljaric · Washington University$4,587,360
- Erik A Willis · Univ Of North Carolina Chapel Hill$3,558,399
Research focus
Early Childhood6 Year OldActive MethodDigitalAxon InjuryAcute Lymphocytic LeukemiaBehaviorAffectAnteriorBrain AbnormalitiesBrain InjuriesBrain VolumeCancer TherapyCerebrospinal FluidChemotherapyChildChildhood Acute Lymphocytic LeukemiaCognitive NeuroscienceBrainContinuance Of LifeDesignDiagnosisDiffusion Magnetic Resonance ImagingEfficacious Intervention
Grant awards (4)
Identifying markers of abnormal neurocognitive trajectories during chemotherapy treatment of childhood acute lymphoblastic leukemia$559,503
R37 · FY2025 · CA · contact PI
Identifying markers of abnormal neurocognitive trajectories during chemotherapy treatment of childhood acute lymphoblastic leukemia$489,128
R37 · FY2024 · CA · contact PI
Identifying markers of abnormal neurocognitive trajectories during chemotherapy treatment of childhood acute lymphoblastic leukemia$531,920
R37 · FY2023 · CA · contact PI
Identifying markers of abnormal neurocognitive trajectories during chemotherapy treatment of childhood acute lymphoblastic leukemia$475,253
R37 · FY2022 · CA · contact PI